| ISIN | LU1159238978 |
|---|---|
| Valor Number | 29067531 |
| Bloomberg Global ID | |
| Fund Name | State Street UK Screened Index Equity Fund I EUR |
| Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
| Fund Provider | State Street Investment Management |
| Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
| Distributor(s) | State Street Global Advisors |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The objective of the Fund is to track the performance of the UK equity market. |
| Peculiarities |
| Current Price * | 18.93 EUR | 15.12.2025 |
|---|---|---|
| Previous Price * | 18.71 EUR | 12.12.2025 |
| 52 Week High * | 19.16 EUR | 11.11.2025 |
| 52 Week Low * | 14.83 EUR | 09.04.2025 |
| NAV * | 18.93 EUR | 15.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 102,192,068 | |
| Unit/Share Assets *** | 82,016,280 | |
| Trading Information SIX | ||
| YTD Performance | +14.86% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +14.29% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
| 1 month | +0.91% |
17.11.2025 - 15.12.2025
17.11.2025 15.12.2025 |
| 3 months | +5.22% |
15.09.2025 - 15.12.2025
15.09.2025 15.12.2025 |
| 6 months | +8.66% |
16.06.2025 - 15.12.2025
16.06.2025 15.12.2025 |
| 1 year | +14.10% |
16.12.2024 - 15.12.2025
16.12.2024 15.12.2025 |
| 2 years | +32.99% |
15.12.2023 - 15.12.2025
15.12.2023 15.12.2025 |
| 3 years | +41.47% |
15.12.2022 - 15.12.2025
15.12.2022 15.12.2025 |
| 5 years | +86.07% |
15.12.2020 - 15.12.2025
15.12.2020 15.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 10.98% | |
|---|---|---|
| HSBC Holdings PLC | 9.36% | |
| Shell PLC | 8.18% | |
| Unilever PLC | 5.64% | |
| GSK PLC | 3.69% | |
| BP PLC | 3.64% | |
| Rio Tinto PLC Ordinary Shares | 3.09% | |
| Barclays PLC | 3.06% | |
| Lloyds Banking Group PLC | 2.89% | |
| National Grid PLC | 2.89% | |
| Last data update | 30.11.2025 | |
| TER *** | 0.30% |
|---|---|
| TER date *** | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.20% |
| Ongoing Charges *** | 0.29% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |